Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.5700
-0.0300 (-5.00%)
Last updated: Feb 26, 2026, 1:59 PM AEST
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 82.12 million as of February 25, 2026. Its market cap has increased by 59.76% in one year.
Market Cap
82.12M
Enterprise Value
72.69M
Revenue
2.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.57
Market Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 82.12M, an increase of 219.52%. That is a compound annual growth rate of 58.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 82.12M | -0.83% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lumos Diagnostics Holdings | 206.24M |
| EMVision Medical Devices | 163.57M |
| SomnoMed | 144.17M |
| Compumedics | 67.92M |
| Micro-X | 50.83M |
| CleanSpace Holdings | 46.53M |
| Nova Eye Medical | 45.57M |
| HeraMED | 40.09M |